Can a simple blood test predict skin cancer outcomes?
NCT ID NCT06608511
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at blood samples from 20 adults with melanoma or other skin cancers to see if certain markers in the blood can predict how well treatment works or how long someone lives. Researchers will compare these markers to standard measures like tumor response and survival. The goal is to find better ways to monitor the disease without relying only on scans or biopsies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
20 people
The number who actually took part.
- Started
-
Dec 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Participants will be from the Melanoma Medical Oncology Clinic at the Carbone Cancer Center.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years. * Participants must meet at least one of the following criteria: * Finding suspicious of melanoma or non-melanoma skin cancer based on clinical, radiographic, or laboratory findings. Non-melanoma skin cancers include: basal cell carcinoma, cutaneous squamous cell carcinoma, and Merkel cell carcinoma. * A confirmed diagnosis of melanoma or non-melanoma skin cancer. Exclusion Criteria: * Vulnerable populations, including pregnant women, those who lack consent capacity, the mentally ill, prisoners, cognitively impaired persons, children (age \<18), and UW employees that report to the investigator(s) or to study team members. * Not suitable for study participation due to other reasons at the discretion of the investigators.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Basal cell carcinoma of skin are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Wisconsin
Madison, Wisconsin, 53705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your gut bacteria may hold the key to whether immunotherapy works
- Can a DNA vaccine teach the immune system to hunt melanoma?
- Can protein patterns in stored tumors point to new treatment targets?
- Can imaging replace the scalpel for skin cancer checks?
- Can a laser microscope diagnose skin cancer faster?
- Can a workplace campaign shade outdoor workers from skin cancer?